ETON · Eton Pharmaceuticals Inc
United States · RS rating 90 · As of 2026-11-03
| Price | 50.95 USD |
|---|---|
| 1-day change | +0.3% |
| RS rating (overall / 1M / 3M / 12M) | 90 / 38 / 82 / 97 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 42 / 50 / 60 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +171.4% |
| Sales growth Q/Q | -5.2% |
| Distance from 52-week high | +20.9% |
| Market cap (USD) | $626.7M |